An asthma patient’s journey from breathless to optimistic*
An asthma patient’s journey from breathless to optimistic*
In this video, we hear from Gary, an individual living with asthma, as he shares his journey from experiencing seasonal asthma to facing respiratory failure. He speaks with Emma, a respiratory nurse consultant, who supported him in managing his symptoms through a combined approach of lifestyle modifications and Fostair® (beclometasone/formoterol) maintenance and reliever therapy (MART) (100/6).
Fostair 100/6 is indicated in the regular treatment of asthma in adults where use of combination product is appropriate: patients not adequately controlled with ICS and ‘as needed’ inhaled rapid-acting β2-agonist or, patients already adequately controlled on both ICS and long-acting β2-agonists.
* Not all patients respond the same way. Treatment should be individualised.
Talk to us
Request a call or meeting with your local Chiesi representative at a time which suits you.
Order training inhalers
Support your patients with their inhaler technique by ordering placebo training inhalers directly from Chiesi.
Sign up for updates
Want to hear more from Chiesi? Opt-in to receive updates on Chiesi Air products and services.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Chiesi Limited on 0800 0092329 (UK) or PV.UK@Chiesi.com.